Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sherlock Biosciences
MedTech
OraSure sees investor pressure, potential proxy fight: report
Infectious disease testmaker OraSure may have a fight brewing over its board of directors following the recent rejection of a buyout offer.
Conor Hale
Sep 9, 2025 12:00pm
CRISPR testmaker Sherlock Biosciences nabs Sense Biodetection
Feb 1, 2023 10:21am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
Sherlock Bio nets $80M to bring CRISPR-based tests into the home
Mar 8, 2022 12:56pm
Case closed: Sherlock Biosciences finds new CEO
Jul 12, 2021 10:05am
Sherlock Bio links with IDT to ship its CRISPR coronavirus test
Jun 8, 2020 10:35am
